QLY Biotech Group (QLY Biotech Group) ROCE % : 0.00% (As of Feb. 2023)

View and export this data going back to 2021. Start your Free Trial

What is QLY Biotech Group ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. QLY Biotech Group's annualized ROCE % for the quarter that ended in Feb. 2023 was 0.00%.

QLY Biotech Group ROCE % Historical Data

The historical data trend for QLY Biotech Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QLY Biotech Group ROCE % Chart

QLY Biotech Group Annual Data

Trend

Aug19

Aug20

Aug21

Aug22

ROCE %

-50.00

-40.00

-352.94

QLY Biotech Group Quarterly Data
	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23
ROCE %	Get a 7-Day Free Trial												-	-	-	-	-

QLY Biotech Group ROCE % Calculation

QLY Biotech Group's annualized ROCE % for the fiscal year that ended in Aug. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Aug. 2022 )		(A: Aug. 2021 )		(A: Aug. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Aug. 2022 )		(A: Aug. 2021 )		(A: Aug. 2022 )
	=	-0.014	/	( ( (0.007 - 0.013)	+	(0 - 0) )	/ 1 )
	=	-0.014	/	( (-0.006	+	0)	/ 1 )
	=	-0.014	/	-0.006
	=	233.33 %

QLY Biotech Group's ROCE % of for the quarter that ended in Feb. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Feb. 2023 )		(Q: Nov. 2022 )		(Q: Feb. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Feb. 2023 )		(Q: Nov. 2022 )		(Q: Feb. 2023 )
	=	-0.048	/	( ( (0 - 0.008)	+	(0 - 0.02) )	/ 2 )
	=	-0.048	/	( ( -0.008	+	-0.02 )	/ 2 )
	=	-0.048	/	-0.014
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Feb. 2023) EBIT data.

QLY Biotech Group (OTCPK:LQLY) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

QLY Biotech Group ROCE % Related Terms

Thank you for viewing the detailed overview of QLY Biotech Group's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

QLY Biotech Group (QLY Biotech Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Travel & Leisure » QLY Biotech Group Corp (OTCPK:LQLY) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

5348 Vegas Drive, Las Vegas, NV, USA, 89108

Website

QLY Biotech Group Corp is a United States based company engaged in the tourism business.

QLY Biotech Group (QLY Biotech Group) Headlines

No Headlines